UII increases cardiomyocyte size, protein/DNA ratio and intracellular Ca2 +, consistent with a hypertrophic response.
UII upregulates the phosphorylation of CaMKII and its downstream target PLN (Thr17), SERCA 2a levels.
UII induces cardiomyocyte hypertrophy through CaMKII-mediated up-regulating of PLN Thr17–phosphorylation signaling pathway.